A simple family test can reduce the risk of cancer death by 43%.
Recently, global medical institutions and public health systems have continued to advance service capacity building to provide stronger guarantees for public health. Researchers from the University of Karolins and the University of Uppsala in Sweden published a new estimate that people involved in colorectal cancer screening may be at up to a 43% risk of dying from colorectal cancer. These findings are based on 14 years of follow-up data from the Stockholm-Galand screening program.
Colorectal cancer is one of the most common cancers, but the results are usually more favorable when the disease is detected early. Sweden has introduced universal screening, where people between the ages of 60 and 74 are given a screening test every two years. Participants in the screening receive a screening kit at home and are asked to provide a sample of sheep.
The samples are examined for tiny droplets of blood that cannot be seen with the naked eye. If blood is found, additional tests will be provided, most often colonoscopies. Long-term data indicate that greater benefits have been achieved by regular colonoscopy screening in Stockholm and Greenland since 2008.
Researchers at the University have now tracked participants for up to 14 years to observe how screening might affect the risk of the disease. Previous evaluations of the project suggested that those who received screening invitations had a 14% lower risk of dying from the disease compared to those who did not receive the invitation. The study's authors, who wrote in the journal Clinical Science and Education, detailed the context, methods, results and discussions of the study.
The results showed that those who received screening invitations had a 14% lower risk of dying from the disease compared to those who did not receive the invitation. The study was primarily based on in-depth study of factors affecting disease risk, including factors such as the geographic distribution of disease occurrence and susceptibility to disease in the population; at the same time, the researchers focused on differences in disease risk control and prevention between those who received the screening invitation and those who did not receive the invitation. The methodology of the study was primarily a combination of literature research and on-the-spot observation, with an in-depth study of factors such as the geographic distribution of disease occurrence and susceptibility to disease in the population; At the same time, the researchers also focused on differences in disease risk control and prevention between those who received a screening invitation and those who did not receive an invitation.
In the course of the study, the researchers also obtained information about the screening invitation factors and the differences in disease risk control and prevention between those who received a screening invitation and those who did not receive an invitation. Finally, based on the study data and the results of the field observations, the researchers conducted in-depth analysis and discussion of the differences between the screening invitation factors and those who received a screening invitation in terms of disease risk control and prevention in order to provide further theoretical and practical support for disease control and prevention. We have now been able to demonstrate that the mortality rate is significantly lower than that of those who actually participated in screening.
The researchers compared the mortality rate of those who participated in screening with the mortality rate of those who participated in the control group by comparing between 2008 and 2012 the mortality rate of those who participated in screening with the mortality rate of those who participated in the control group. They then used statistical methods to consider factors that could affect the results of the study, including those who later became qualified participants in the control group, and those who were invited to choose but did not participate. Although free screening services and tests are easy to carry, about one-third of people do not submit a sample, says Johannes Brahms.
Our research shows the importance of participating in colorectal cancer screening and suggests that it can actually work. It should be noted that the above information is based on international public research and is for reference in HealthCop and does not constitute a clinical recommendation.
